Raloxifene Side Effects: Common, Serious, and When to Worry

Common Side Effects of Raloxifene

The side effects reported most frequently in clinical trials and in post-marketing use include:

• Hot flashes — the single most common complaint, especially in the first 6 months;
• Leg cramps and muscle aches;
• Peripheral edema — mild swelling of the lower legs or ankles;
• Joint pain (arthralgia);
• Sinus and throat irritation, sometimes mild flu-like symptoms;
• Increased sweating, particularly at night;
• Occasional headache.

These effects are usually mild to moderate. In the MORE trial, the rate of women discontinuing raloxifene because of side effects was modestly higher than placebo — significant but not large.^[3] Many of these symptoms ease within the first 3 to 6 months of treatment.

Hot Flashes on Raloxifene: Why They Happen

It can be confusing — even frustrating — that a medication associated with estrogen receptors causes hot flashes, which are usually associated with low estrogen. The explanation lies in raloxifene’s tissue-selective behavior. In the hypothalamus, where the body regulates temperature, raloxifene acts as an estrogen antagonist, blocking the receptor rather than mimicking estrogen. The result is a state that, from the hypothalamus’s perspective, looks like low estrogen — and produces vasomotor symptoms much like menopause itself.

For most women, hot flashes are most intense in the first 1 to 3 months, ease over the next 3 to 6 months, and become manageable or resolve. A smaller group finds them persistent enough to seriously affect quality of life. Importantly, raloxifene is not a treatment for hot flashes and will not relieve menopausal vasomotor symptoms — if hot flash relief is your priority, raloxifene is not the right tool.

Leg Cramps and Muscle Aches

Leg cramps — particularly nocturnal cramps in the calves or thighs — are the second most common complaint. The mechanism is not fully established. Most cramps respond to:

• Adequate hydration through the day;
• Stretching, especially before bed;
• Gentle, regular weight-bearing exercise (which also benefits bone density);
• Ensuring adequate magnesium, calcium, and electrolyte intake.

Most cramps are benign and improve with time. However, cramping that comes on suddenly in one leg, especially with swelling, warmth, redness, or tenderness, is not a routine raloxifene side effect — it can signal a deep vein thrombosis (DVT) and should be evaluated urgently.

Serious Side Effects: When to Call Your Doctor

The serious risks of raloxifene are clearly defined in the FDA boxed warning and across decades of clinical trial data. Each is genuinely uncommon, but each is important enough that you should know the warning signs.

Venous thromboembolism (DVT, PE, retinal vein thrombosis)

Raloxifene increases the risk of blood clots roughly 2- to 3-fold compared with placebo — similar in magnitude to oral estrogen therapy. The highest-risk window is the first 4 months of use. Warning signs that warrant urgent medical attention include:

• Pain, swelling, redness, or warmth in one leg, especially the calf;
• Sudden shortness of breath, sharp chest pain, or coughing up blood;
• Sudden loss or change in vision, especially in one eye.

Raloxifene should be paused before extended immobilization, including planned surgery and long-haul travel, and stopped immediately if a clot is suspected.

Increased risk of fatal stroke in certain women

In the RUTH trial of women with documented coronary disease or significant cardiovascular risk factors, raloxifene did not change the overall rate of strokes but was associated with a small but statistically significant increase in fatal strokes.^[2] This is the basis for the boxed warning. The signal was not seen in lower-risk postmenopausal populations.

Liver effects

Severe liver impairment is a contraindication, and raloxifene should be used with caution in moderate impairment. Unexplained nausea, jaundice (yellowing of skin or eyes), dark urine, or persistent right-upper-abdominal discomfort warrants prompt evaluation.

Hypersensitivity and rash

Skin reactions, including rare cases of erythema multiforme and other significant rashes, have been reported. Any new severe rash, mouth sores, or fever in combination with rash should be evaluated.

Raloxifene Contraindications

Raloxifene is contraindicated — meaning it should not be used — in the following situations:

• Active or past venous thromboembolism: DVT, PE, or retinal vein thrombosis at any point in life;
• Pregnancy or potential pregnancy (FDA Pregnancy Category X);
• Breastfeeding;
• Premenopausal status — safety and efficacy not established;
• Severe hepatic impairment;
• Concurrent systemic estrogen therapy (combination not studied and not recommended).

Caution and individualized risk-benefit assessment are warranted in:

• Women with a history of stroke, transient ischemic attack, or atrial fibrillation;
• Women with significant cardiovascular risk factors (because of the RUTH stroke signal);
• Women planning prolonged immobilization (surgery, travel) — pause raloxifene if possible;
• Women on highly protein-bound medications such as warfarin, where dose adjustment may be needed.

Long-Term Side Effects

Raloxifene has one of the longer follow-up datasets in the SERM class: the MORE/CORE extension monitored women for up to 8 years.^[3] Key long-term observations:

• Bone-density benefit is maintained with continued use;
• Breast cancer risk-reduction benefit accumulates over years;
• Venous thromboembolism risk remains elevated throughout treatment, though absolute event rates remain low in average-risk women;
• Endometrial cancer rates did not differ significantly from placebo;
• Overall mortality was not increased.

Long-term users should keep follow-up appointments, repeat DXA scans on the schedule their clinician recommends, and remain alert to clot warning signs.

How to Manage Common Side Effects

Practical strategies that have helped many women on raloxifene:

• Hot flashes: dress in layers, keep the bedroom cool, identify and reduce triggers (alcohol, hot drinks, spicy food). If your mood and sleep are suffering, raise it at your next visit — there are non-hormonal options for hot flashes that can be used alongside raloxifene where appropriate.
• Leg cramps: stretch calves before bed, stay hydrated, walk daily, ensure adequate magnesium intake. Persistent or unilateral cramping with swelling needs evaluation.
• Joint pain: regular movement, weight management, and treating other contributors (e.g., osteoarthritis) help. New, severe, or asymmetric joint pain should be discussed.
• Mild edema: usually self-limiting; if persistent or significant, mention to your provider.
• Adherence: link the dose to a daily habit; many side effects fade with time, so consistency in those first few months often pays off.

If Side Effects Are Severe: Considering Your Options

For some women, raloxifene side effects either don’t improve or are intolerable from the start. For others, the risk-benefit balance simply doesn’t feel right after living with the medication for a while. Both are legitimate reasons to revisit the conversation.

The first step is rarely to stop the medication on your own. Raloxifene’s benefits on fracture risk and breast cancer prevention are real, and your risk profile is the lens through which side effects need to be weighed. The right next step is usually a careful conversation with a clinician who knows the full landscape of options.

There are other approaches for both osteoporosis prevention and breast cancer risk reduction — bisphosphonates, denosumab, aromatase inhibitors (where appropriate), lifestyle interventions, and in some women, systemic hormone therapy with appropriate risk assessment. A hormone-trained provider can review your full picture and help you decide whether raloxifene remains the best fit, or whether an alternative — discussed in detail on the raloxifene alternatives page — might suit you better.